Literature DB >> 16226385

Reduced calcium binding protein immunoreactivity induced by electroconvulsive shock indicates neuronal hyperactivity, not neuronal death or deactivation.

J-E Kim1, S-E Kwak, D-S Kim, M H Won, O-S Kwon, S-Y Choi, T-C Kang.   

Abstract

Calcium-binding proteins (CBPs), such as parvalbumin and calbindin D-28k, are useful markers of specific neuronal types in the CNS. In recent studies, expression of CBPs may be indicative of a deactivated neuronal state, particularly epilepsy. However, it is controversial whether altered expression of CBPs in the hippocampus practically indicate neuronal activity. Therefore, the present study was performed to investigate the extent of profiles of expression of CBPs in the rat hippocampus affected by several episodes induced by electroconvulsive shock. In the present study, following electroconvulsive shock expression of CBPs were reduced in the hippocampus in a stimulus-dependent manner, and recovered to the control level at 6 h after electroconvulsive shock. However, paired-pulse responses of the dentate gyrus were transiently impaired by electroconvulsive shock, and immediately normalized to baseline value. In addition, effects of electroconvulsive shock on expression of CBPs and paired-pulse responses were prevented by pretreatment of vigabatrin. These findings suggest that reduced expression of CBPs induced by seizure activity may be indicative of hyperactivity of CBP positive neurons, which is a practical consequence of the abnormal discharge, and that they may play an important role in regulating seizure activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226385     DOI: 10.1016/j.neuroscience.2005.08.052

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Proportional loss of parvalbumin-immunoreactive synaptic boutons and granule cells from the hippocampus of sea lions with temporal lobe epilepsy.

Authors:  Starr Cameron; Ariana Lopez; Raisa Glabman; Emily Abrams; Shawn Johnson; Cara Field; Frances M D Gulland; Paul S Buckmaster
Journal:  J Comp Neurol       Date:  2019-03-22       Impact factor: 3.215

2.  Compensatory regulation of Cav2.1 Ca2+ channels in cerebellar Purkinje neurons lacking parvalbumin and calbindin D-28k.

Authors:  Lisa Kreiner; Carl J Christel; Morris Benveniste; Beat Schwaller; Amy Lee
Journal:  J Neurophysiol       Date:  2009-11-11       Impact factor: 2.714

3.  Grafting of striatal precursor cells into hippocampus shortly after status epilepticus restrains chronic temporal lobe epilepsy.

Authors:  Bharathi Hattiangady; Muddanna S Rao; Ashok K Shetty
Journal:  Exp Neurol       Date:  2008-05-15       Impact factor: 5.330

4.  Decline in age-dependent, MK801-induced injury coincides with developmental switch in parvalbumin expression: somatosensory and motor cortex.

Authors:  Carla M Lema Tomé; Ryan Miller; Clayton Bauer; Chelsey Smith; Kaitlin Blackstone; Adam Leigh; Jamie Busch; Christopher P Turner
Journal:  Dev Psychobiol       Date:  2008-11       Impact factor: 3.038

5.  Restoration of calbindin after fetal hippocampal CA3 cell grafting into the injured hippocampus in a rat model of temporal lobe epilepsy.

Authors:  Ashok K Shetty; Bharathi Hattiangady
Journal:  Hippocampus       Date:  2007       Impact factor: 3.899

6.  Immunocytochemical Localization of Calbindin D28K, Calretinin, and Parvalbumin in Bat Superior Colliculus.

Authors:  Se-Jin Jeong; Hyun-Ho Kim; Won-Sig Lee; Chang-Jin Jeon
Journal:  Acta Histochem Cytochem       Date:  2014-06-26       Impact factor: 1.938

7.  Rapid and stable changes in maturation-related phenotypes of the adult hippocampal neurons by electroconvulsive treatment.

Authors:  Yuki Imoto; Eri Segi-Nishida; Hidenori Suzuki; Katsunori Kobayashi
Journal:  Mol Brain       Date:  2017-03-02       Impact factor: 4.041

8.  Altered expression of parvalbumin immunoreactivity in rat main olfactory bulb following pilocarpine-induced status epilepticus.

Authors:  Yeon Hee Yu; Dae-Kyoon Park; Dae Young Yoo; Duk-Soo Kim
Journal:  BMB Rep       Date:  2020-04       Impact factor: 4.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.